ATEC Alphatec Holdings, Inc.

BULLISH Impact: 8/10 8-K
Horizon weeks Filed Feb 24, 2026 Processed 3mo ago SEC 0001193125-26-067062
8-K Item 2.02: Earnings release
Final — all horizons settled through T+60d
ATEC ▼ -41.31% at T+60d
LONG call ✗ call lost -41.31% · α vs SPY -48.26% · entry $14.04 → $8.24
Currently $8.28 · -41.03% from $14.04 entry
Entry anchored
Feb 24, 03:59 PM ET
via Databento tick
T+1d
-0.21%
call -0.21% · α +0.33%
$14.01
settled 4mo ago
T+5d
-7.41%
call -7.41% · α -6.31%
$13.00
settled 3mo ago
T+20d
-18.16%
call -18.16% · α -12.93%
$11.49
settled 3mo ago
T+60d
-41.31%
call -41.31% · α -48.26%
$8.24
settled 24d ago

Price Chart

Loading chart...

Executive Summary

Alphatec Holdings reported strong 2025 financial results with full-year revenue growing 25% to $764 million and non-GAAP net income of $8 million. The company raised its 2026 guidance, now expecting approximately $890 million in revenue and $134 million in adjusted EBITDA, reflecting continued operating leverage and a pivotal transition to positive free cash flow.

Key Financial Metrics

Revenue
$764.0M
+25.0% YoY
Adj. EPS
$0.05
GAAP: $-0.96
Guidance
$890 million
raised
Free Cash Flow
$3.0M
Gross Margin
70%

Actionable Insight

The significant revenue growth, margin expansion, and transition to positive free cash flow suggest strong execution and market adoption. The raised guidance indicates confidence in continued momentum, making this a potentially attractive opportunity for investors focused on medical device companies with improving fundamentals.

Key Facts

  • Full-year 2025 revenue grew 25% to $764 million
  • Non-GAAP net income was $8 million for 2025
  • Company achieved positive free cash flow of $3 million for the full year
  • 2026 revenue guidance increased to approximately $890 million (17% growth)
  • 2026 adjusted EBITDA guidance raised to $134 million (15% margin)
  • Company expects to generate at least $20 million of free cash flow in 2026

Financial Impact

Revenue growth of 25% in 2025, with 17% growth expected in 2026. Adjusted EBITDA margin expanded from 12% to 15% in guidance.

revenueepsmarginscashFlow

Segment Breakdown

SegmentRevenueGrowth
Surgical$764.0M+21.0%
EOS

Risk Factors

  • GAAP net loss of $143 million indicates ongoing profitability challenges on a reported basis
  • Guidance is forward-looking and subject to risks mentioned in the filing

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-067062
Document: atec-20260224.htm0001193125-26-067062
Document: 0001193125-26-067062-index-headers.html0001193125-26-067062
Document: 0001193125-26-067062-index.html0001193125-26-067062
Document: 0001193125-26-067062.txt0001193125-26-067062
5 reports for ATEC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ATEC — sortable, filterable
Type Now
Jun 11, 2026
1d ago
144
NEUTRAL ★ 2/10
$8.15 awaiting T+60awaiting T+60$8.28 (+1.60%)
Jun 11, 2026
1d ago
Institutional Cluster
BULLISH ★ 5/10
$8.10 awaiting T+60awaiting T+60$8.28 (+2.22%)
Mar 11, 2026
13w ago
Insider Cluster
BEARISH ★ 7/10
$12.66 $7.68▲ +39.34%▲ +50.86%$8.28 (+34.60%)
Mar 5, 2026
14w ago
Insider Cluster
BEARISH ★ 6/10
$12.57 $7.48▲ +40.49%▲ +51.79%$8.28 (+34.13%)
Feb 24, 2026
15w ago
8-K
BULLISH ★ 8/10
$14.04 $8.24▼ −41.31%▼ −48.26%$8.28 (−41.03%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (49h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access